Director, Strategy Advisory Board

Whitney K. Stearns (Whit) serves as a Director of ACCOY Pharmaceuticals, Inc.'s Strategy Advisory Board. He is the Chief Financial Officer of JDS Therapeutics and is an experienced financial executive with over 28 years of directly related generics and branded products pharmaceutical industry experience in private, venture backed start-up and publicly (NASDAQ and NYSE) traded companies (URL Pharma, Inc., JDS Pharmaceuticals, LLC, Phytoceutica, Inc., and Schein Pharmaceuticals). He has directed all financial activities, financings, cash flow, reporting; managed commercial lender, banking, and investment banking relationships; been responsible for a successful NYSE IPO; has developed and participated in domestic and international road shows, and created investor relations programs that actively supported analyst coverage; established financial and business systems from the ground up, including accounting, pre-clinical and clinical tracking, budgeting and financial reporting systems; managed the financial efforts of three successful strategic investor exit transactions (two at over $800 million, one at $125 million); and participated in myriad company and product acquisitions, divestment, and licensing deals. His successful career has provided him with a deep understanding of how and what needs to be done at each stage of company growth and product commercialization. Mr. Stearns began his financial career as a CPA with KPMG and rose to the level of audit partner. Whit received a B.S. in Accounting from Lehigh University.